Nuveen Asset Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $526K | Buy |
330,831
+63,096
| +24% | +$100K | ﹤0.01% | 2967 |
|
|
2024
Q3 | $525K | Hold |
267,735
| – | – | ﹤0.01% | 3002 |
|
|
2024
Q2 | $439K | Hold |
267,735
| – | – | ﹤0.01% | 3035 |
|
|
2024
Q1 | $1.38M | Hold |
267,735
| – | – | ﹤0.01% | 2564 |
|
|
2023
Q4 | $1.53M | Buy |
267,735
+18,695
| +8% | +$107K | ﹤0.01% | 2530 |
|
|
2023
Q3 | $1.19M | Buy |
249,040
+16,162
| +7% | +$77.3K | ﹤0.01% | 2505 |
|
|
2023
Q2 | $990K | Sell |
232,878
-60,086
| -21% | -$255K | ﹤0.01% | 2657 |
|
|
2023
Q1 | $1.56M | Sell |
292,964
-13,922
| -5% | -$73.9K | ﹤0.01% | 2435 |
|
|
2022
Q4 | $1.93M | Buy |
306,886
+83,479
| +37% | +$524K | ﹤0.01% | 2403 |
|
|
2022
Q3 | $2.36M | Sell |
223,407
-31,459
| -12% | -$332K | ﹤0.01% | 2317 |
|
|
2022
Q2 | $1.38M | Buy |
254,866
+62,686
| +33% | +$340K | ﹤0.01% | 2628 |
|
|
2022
Q1 | $1.76M | Buy |
192,180
+129,399
| +206% | +$1.18M | ﹤0.01% | 2560 |
|
|
2021
Q4 | $1.01M | Sell |
62,781
-3,007
| -5% | -$48.5K | ﹤0.01% | 2859 |
|
|
2021
Q3 | $1.57M | Buy |
+65,788
| New | +$1.57M | ﹤0.01% | 2788 |
|